The Q2 2013 report is part two in a four-part quarterly series. It is an in-depth look at the deal activity of mergers and acquisitions in the U.S.
This 18-page report features in depth analysis and 19 data charts along with invaluable insight that you will take away:
- Merger and acquisition activity fell to 229 deals from 249 in the first quarter, but higher values on individual deals drove total dollar volume to near record levels at $49.9 billion.
- Several major mergers drove the higher deal dollar value, including Thermo Fisher Scientific's takeover of Life Technologies Corp. for $13.6 billion and Valeant Pharmaceuticals' purchase of Bausch & Lomb for $8.7 billion.
- Hospital mergers seized center stage with two of the top five deals during the quarter led by Tenet Healthcare Corp.'s takeover of Vanguard Health Systems for $4.3 billion.
- Providers led the pack in making deals in the second quarter, with hospitals and other provider groups announcing 106 transactions, nearly double its previous quarter's total.
If there are any questions, please call 312-397-5511 or e-mail [email protected].